Literature DB >> 29671142

What should we know about the person behind a TTO?

Floortje van Nooten1, Jan Busschbach2, Michel van Agthoven3, Job van Exel1, Werner Brouwer4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29671142     DOI： 10.1007/s10198-018-0975-1

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  38 in total

1.  To what extent can we explain time trade-off values from other information about respondents?

Authors:  Paul Dolan; Jennifer Roberts
Journal:  Soc Sci Med       Date:  2002-03       Impact factor: 4.634

Review 2.  Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.

Authors:  Trude Arnesen; Mari Trommald
Journal:  Health Econ       Date:  2005-01       Impact factor: 3.046

3.  Correcting biases in standard gamble and time tradeoff utilities.

Authors:  Sylvie M C van Osch; Peter P Wakker; Wilbert B van den Hout; Anne M Stiggelbout
Journal:  Med Decis Making       Date:  2004 Sep-Oct       Impact factor: 2.583

4.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

5.  Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Authors:  Donna Rowen; John Brazier; Tracey Young; Sabine Gaugris; Benjamin M Craig; Madeleine T King; Galina Velikova
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

6.  Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.

Authors:  Victor Zarate; Paul Kind; Ling-Hsiang Chuang
Journal:  Value Health       Date:  2008-05-16       Impact factor: 5.725

7.  A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.

Authors:  Nancy J Devlin; Aki Tsuchiya; Ken Buckingham; Carl Tilling
Journal:  Health Econ       Date:  2011-03       Impact factor: 3.046

8.  Assessing values for health: numeracy matters.

Authors:  S Woloshin; L M Schwartz; M Moncur; S Gabriel; A N Tosteson
Journal:  Med Decis Making       Date:  2001 Sep-Oct       Impact factor: 2.583

9.  Sensitivity and perspective in the valuation of health status: whose values count?

Authors:  G A De Wit; J J Busschbach; F T De Charro
Journal:  Health Econ       Date:  2000-03       Impact factor: 3.046

Review 10.  Patient and general public preferences for health states: A call to reconsider current guidelines.

Authors:  M M Versteegh; W B F Brouwer
Journal:  Soc Sci Med       Date:  2016-07-31       Impact factor: 4.634
View more
  6 in total

1.  Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China.

Authors:  Shuang Hao; Emelie Heintz; Gert Helgesson; Sophie Langenskiöld; Jiaying Chen; Kristina Burström
Journal:  Qual Life Res       Date:  2019-09-12       Impact factor: 4.147

2.  Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  Qual Life Res       Date:  2021-10-30       Impact factor: 3.440

3.  Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  MDM Policy Pract       Date:  2022-03-07

4.  Self-esteem in patients with venous thromboembolism predicts time trade-off values for own health.

Authors:  Peep F M Stalmeier; Eva E Volmeijer
Journal:  Health Qual Life Outcomes       Date:  2022-03-05       Impact factor: 3.186

5.  Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  Eur J Health Econ       Date:  2022-09-02

6.  Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.

Authors:  Tonya Moen Hansen; Ylva Helland; Liv Ariane Augestad; Kim Rand; Knut Stavem; Andrew Garratt
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.